Home NuSight Medical

NuSight Medical

NuSight Medical Announces Issuance of U.S. Patent Covering the NuLids System® for Treating Dry Eye Disease

U.S. Patent No. 10,314,763 covers the use of the NuLids System treatment for the treatment of dry eye/ocular surface disease, blepharitis and related conditions. “The patent protects our entire NuLids system – the device and methods for its use, the disposable soft-tips, and product safety features” said Robert Foster, CEO of NuSight Medical.

Must Read

New Study Validates Rigorous Safety Measures Needed To Reduce Mercury Exposure During Dental Amalgam Filling Removal

"For decades, our non-profit organization has been concerned about this issue and collected research about amalgam fillings, all of which contain approximately 50% mercury, a known neurotoxin," explains IAOMT President Michael Rehme, DDS, NMD.  "Based on this science, we have strongly recommended that safety measures be enacted for dental procedures involving these silver-colored fillings, and we have also intensely advocated for the end of dental amalgam usage."

New Research Demonstrates Advantages of ExactechGPS® for Knee and Shoulder Joint Replacement

ExactechGPS is a dynamic computer-assisted technology that enhances the surgical experience with active intraoperative feedback for real-time execution in a compact and mobile system within the sterile field.